Jacobs Levy Equity Management Portfolio holdings
AUM
$25.5B
1-Year Return
20.81%
This Quarter Return
+4.44%
1 Year Return
+20.81%
3 Year Return
+97.14%
5 Year Return
+210.43%
10 Year Return
+444.59%
AUM
$28.3B
AUM Growth
+$2.33B
(+9%)
Cap. Flow
+$1.67B
Cap. Flow
% of AUM
5.92%
Top 10 Holdings %
Top 10 Hldgs %
25.96%
Holding
1,069
New
128
Increased
377
Reduced
389
Closed
143
Top Buys
| 1 |
Arista Networks
ANET
|
$382M |
| 2 |
Lam Research
LRCX
|
$269M |
| 3 |
Palo Alto Networks
PANW
|
$251M |
| 4 |
GE Vernova
GEV
|
$227M |
| 5 |
Apple
AAPL
|
$163M |
Top Sells
| 1 |
Amphenol
APH
|
$273M |
| 2 |
Intuit
INTU
|
$211M |
| 3 |
CrowdStrike
CRWD
|
$209M |
| 4 |
Williams-Sonoma
WSM
|
$192M |
| 5 |
Old Dominion Freight Line
ODFL
|
$130M |
Sector Composition
| 1 | Technology | 30.62% |
| 2 | Financials | 14.28% |
| 3 | Consumer Discretionary | 13.84% |
| 4 | Industrials | 12.66% |
| 5 | Healthcare | 9.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
726
Flexsteel Industries
FLXS
$260M
| $913K | ﹤0.01% |
16,807
+6,005
| +56% | +$326K |
|
727
Preformed Line Products
PLPC
$951M
| $905K | ﹤0.01% |
7,085
| – | – |
|
728
Editas Medicine
EDIT
$250M
| $900K | ﹤0.01% |
708,409
+178,575
| +34% | +$227K |
|
729
Adaptive Biotechnologies
ADPT
$1.94B
| $900K | ﹤0.01% |
150,071
+6,392
| +4% | +$38.3K |
|
730
Lyell Immunopharma
LYEL
$239M
| $887K | ﹤0.01% |
+69,265
| New | +$887K |
|
731
Astera Labs
ALAB
$36.4B
| $886K | ﹤0.01% |
+6,690
| New | +$886K |
|
732
Thryv Holdings
THRY
$554M
| $880K | ﹤0.01% |
59,488
+32,211
| +118% | +$477K |
|
733
KLA
KLAC
$120B
| $874K | ﹤0.01% |
1,387
-2,364
| -63% | -$1.49M |
|
|
AHH
734
Armada Hoffler Properties
AHH
$588M
| $872K | ﹤0.01% |
85,240
-62
| -0.1% | -$634 |
|
735
iHeartMedia
IHRT
$338M
| $870K | ﹤0.01% |
+439,215
| New | +$870K |
|
736
Lindblad Expeditions
LIND
$764M
| $856K | ﹤0.01% |
72,166
-14,958
| -17% | -$177K |
|
737
Prelude Therapeutics
PRLD
$68.5M
| $850K | ﹤0.01% |
666,574
+491,595
| +281% | +$627K |
|
738
Climb Global Solutions
CLMB
$588M
| $846K | ﹤0.01% |
6,675
-104
| -2% | -$13.2K |
|
739
Birkenstock
BIRK
$8.99B
| $837K | ﹤0.01% |
14,778
+688
| +5% | +$39K |
|
740
Primis Financial Corp
FRST
$275M
| $836K | ﹤0.01% |
71,667
-53,944
| -43% | -$629K |
|
741
Xerox
XRX
$482M
| $835K | ﹤0.01% |
+99,012
| New | +$835K |
|
742
W.W. Grainger
GWW
$47.6B
| $830K | ﹤0.01% |
787
-294
| -27% | -$310K |
|
743
Dell
DELL
$83.5B
| $829K | ﹤0.01% |
7,190
| – | – |
|
|
LIF
744
Life360
LIF
$7.97B
| $828K | ﹤0.01% |
+20,064
| New | +$828K |
|
745
Eagle Materials
EXP
$7.75B
| $828K | ﹤0.01% |
3,354
-15,184
| -82% | -$3.75M |
|
746
Owens Corning
OC
$13B
| $828K | ﹤0.01% |
4,859
+810
| +20% | +$138K |
|
747
PMV Pharmaceuticals
PMVP
$74.7M
| $815K | ﹤0.01% |
539,893
-165,700
| -23% | -$250K |
|
748
Eagle Bancorp
EGBN
$597M
| $807K | ﹤0.01% |
+30,984
| New | +$807K |
|
749
United Therapeutics
UTHR
$17.7B
| $800K | ﹤0.01% |
2,268
| – | – |
|
750
Hudson Technologies
HDSN
$448M
| $791K | ﹤0.01% |
+141,772
| New | +$791K |
|